Skye Bioscience, Inc. Quarterly Common Stock, Shares, Outstanding from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Skye Bioscience, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2012 to Q3 2024.
  • Skye Bioscience, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 30.3M shares, a 146% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 30.3M +18M +146% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 28.1M -943M -97.1% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 28.1M -943M -97.1% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 12.3M +8.7M +238% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 12.3M -484M -97.5% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 972M +476M +95.9% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 972M +476M +95.9% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 3.65M -472M -99.2% Dec 31, 2022 10-K 2024-03-22
Q3 2022 496M +19.8M +4.16% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 496M +99.8M +25.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 496M +128M +34.9% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 476M +188M +65.3% Dec 31, 2021 10-K 2023-03-31
Q3 2021 476M +226M +90.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 396M +213M +116% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 368M +184M +101% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 288M +105M +57.5% Dec 31, 2020 10-K 2022-03-28
Q3 2020 250M +116M +86.5% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 183M +49.1M +36.6% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 183M +49.3M +36.8% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 183M +49M +36.6% Dec 31, 2019 10-K 2021-03-02
Q3 2019 134M +650K +0.49% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 134M +1.39M +1.05% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 134M +1.49M +1.13% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 134M +100M +298% Dec 31, 2018 10-K 2020-03-23
Q3 2018 133M +103M +335% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 133M +102M +337% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 132M +105M +385% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 33.6M +12.1M +55.9% Dec 31, 2017 10-K 2019-03-14
Q3 2017 30.7M +10.8M +54% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 30.3M +10.4M +52.3% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 27.3M +7.4M +37.1% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 21.6M +1.66M +8.34% Dec 31, 2016 10-K 2018-03-19
Q3 2016 19.9M +1.84M +10.2% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 19.9M +3.65M +22.4% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 19.9M +3.65M +22.4% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 19.9M +3.9M +24.4% Dec 31, 2015 10-K 2017-03-10
Q3 2015 18.1M +6.31M +53.6% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 16.3M +12.6M +349% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 16.3M +12.6M +349% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 16M +8.23M +106% Dec 31, 2014 10-K 2016-03-21
Q3 2014 11.8M +8.15M +225% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 3.62M +476K +15.1% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 3.62M +476K +15.1% Apr 30, 2014 10-Q 2014-06-05
Q4 2013 7.77M Dec 31, 2013 10-K 2015-03-27
Q3 2013 3.62M +1.1M +43.4% Oct 31, 2013 10-Q 2014-09-15
Q2 2013 3.15M Jul 31, 2013 10-Q 2013-09-16
Q1 2013 3.15M Apr 30, 2013 10-Q 2013-06-27
Q3 2012 2.53M Oct 31, 2012 10-K 2014-01-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.